Speaker:
Brittany Lam

Learning Objectives:

• Describe the pathophysiology, clinical presentation, and diagnosis of patients with cardiac amyloidosis
• Understand the mechanism of action, pharmacokinetics and clinical uses for disease-modifying therapies in cardiac amyloidosis
• Discuss the available literature on treatment options for AL-CM (amyloid light chain cardiomyopathy) and ATTR-CM (amyloid transthyretin cardiomyopathy)

Disclosure:
Brittany has no relevant financial relationships to disclose.